Cellid Co. Ltd (299660) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.031x

Based on the latest financial reports, Cellid Co. Ltd (299660) has a cash flow conversion efficiency ratio of -0.031x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.30 Billion ≈ $-1.56 Million USD) by net assets (₩74.21 Billion ≈ $50.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cellid Co. Ltd (299660) net asset quality to measure how much of total assets are equity-financed.

Cellid Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Cellid Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Cellid Co. Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Cellid Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cellid Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PTL LTD Ordinary Shares NASDAQ:PTLE	-0.445x
Unite Group PLC LSE:UTG	0.019x
Hudson Global Inc NASDAQ:HSON	0.003x
Corem Property Group AB (publ) ST:CORE-A	0.001x
Tourindo Guide Indonesia Pt JK:PGJO	0.979x
Radana Bhaskara Finance Tbk JK:HDFA	-0.240x
EYG Gayrimenkul Yatirim Ortakligi A.S. IS:EYGYO	0.020x
Monalisa KO:012690	0.021x

Annual Cash Flow Conversion Efficiency for Cellid Co. Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Cellid Co. Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Cellid Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩74.21 Billion ≈ $50.29 Million	₩-10.22 Billion ≈ $-6.92 Million	-0.138x	+31.65%
2024-12-31	₩51.20 Billion ≈ $34.70 Million	₩-10.32 Billion ≈ $-6.99 Million	-0.201x	-14.66%
2023-12-31	₩40.50 Billion ≈ $27.44 Million	₩-7.12 Billion ≈ $-4.82 Million	-0.176x	+67.73%
2022-12-31	₩22.44 Billion ≈ $15.21 Million	₩-12.22 Billion ≈ $-8.28 Million	-0.544x	-157.14%
2021-12-31	₩38.76 Billion ≈ $26.27 Million	₩-8.21 Billion ≈ $-5.56 Million	-0.212x	-166.09%
2020-12-31	₩47.30 Billion ≈ $32.05 Million	₩-3.76 Billion ≈ $-2.55 Million	-0.080x	-112.62%
2019-12-31	₩51.33 Billion ≈ $34.79 Million	₩-1.92 Billion ≈ $-1.30 Million	-0.037x	+74.67%
2018-12-31	₩13.50 Billion ≈ $9.15 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.148x	-159.53%
2017-12-31	₩-5.53 Billion ≈ $-3.75 Million	₩-1.37 Billion ≈ $-929.53K	0.248x	-96.60%
2016-12-31	₩-205.83 Million ≈ $-139.49K	₩-1.50 Billion ≈ $-1.02 Million	7.306x	--

About Cellid Co. Ltd

KQ:299660 Korea Biotechnology

Market Cap

$34.53 Million

₩50.95 Billion KRW

Market Cap Rank

#23226 Global

#1525 in Korea

Share Price

₩1727.00

Change (1 day)

+1.17%

52-Week Range

₩1025.00 - ₩4245.00

All Time High

₩127128.20